When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to be skeptical about buying into venture-backed initial public offerings, ...
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
Included Health filed its S-1 for an IPO that never happened. Its CEO said the company went heads-down to reach profitability and sales growth.
Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...
By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to ...
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...
Titan America, which makes heavy building materials and operates primarily on the U.S. Eastern Seaboard, on Tuesday said it plans to sell 9 million shares at between $15 and $18 apiece in the IPO, for ...
Venture Global is the second-largest exporter of liquefied natural gas, or LNG, in the United States, and one of Trump's ...
Titan America SA ("Titan America"), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback